Revised. Amendments from Version 1
==================================

The major changes we have made according to comments from reviewers are below: Added a new table (Table 2) listing detailed information about actions performed in the use case workflow.We have updated Figure 2 by changing words \"Download Diagram\" to \"Export Diagram\" in the figure.Added some new words in the main text (the second paragraph in the Workflow section) to provide ReactomeFIViz CyREST API function names, assisting readers to understand how to reproduce the workflow without going to the Jupyter notebook. Added a sentence to describe the overlapped genes between OV modules and two BRCA modules, 13 and 17, which are not significantly overlapped with any OV module.

Introduction
============

Pathway- and network-based computational approaches are now routinely used in large-scale data analysis to uncover hidden patterns that are otherwise impossible to discover. These approaches project significant genes, proteins, metabolites, and other kinds of biological entities collected from other approaches onto the context of pathways and networks, knowledge produced by many years' experimental studies. [Cytoscape](http://www.cytoscape.org/) ^[@ref-1]^ is the most popular biological network visualization and analysis platform, widely used in the research community to perform pathway and network analysis and visualization. The release of the CyREST app ^[@ref-2]^ enables Cytoscape as an integrative and indisposable tool to build automatic software pipeline and workflow in programming languages widely used by the bioinformatics and computational biology community, including [Python](https://www.python.org/) and [R](https://www.r-project.org/), via a RESTful API. The standalone Java-based Cytoscape application thereby functions as a microservice servlet exposing the major features of Cytoscape.

[Reactome](https://reactome.org/) ^[@ref-3]^ is the most comprehensive open source biological pathway knowledgebase, widely used in the research community, with its web site accessed by roughly 60,000 unique IP addresses per month. To perform genome-scale network-based data analysis and visualization, we have also constructed a highly reliable Reactome functional interaction (FI) network by extracting FIs from manually curated pathways from Reactome and other popular large-scale pathway databases and predicting FIs based on a machine learning approach ^[@ref-4]^. Based on this FI network and the high quality Reactome pathways, we have developed a Cytoscape app, called "ReactomeFIViz" ^[@ref-5]^, which is one of most popular Cytoscape apps, downloaded over 30,000 times since it was released in September, 2013 into Cytoscape app store.

ReactomeFIViz provides a suite of features to help users to perform pathway- and network-based data analysis and visualization for cancer and other complicated diseases. Users can construct a FI subnetwork based on a set of genes, perform network clustering, annotate found network modules using Reactome pathways and Gene Ontology terms, and perform survival analysis if clinical data is available to search for gene signatures related to patient overall survival. Users can also explore Reactome pathways directly inside Cytoscape, perform pathway enrichment analysis for a set of genes, and conduct pathway modeling using multiple types of omics data based on factor graphs converted automatically from Reactome pathways. Recently we added new features for users to visualize FDA approved cancer drugs and their targets interactions in the context of Reactome pathways and the FI network, and perform fuzzy logic based modeling to study the effects of drug application on the pathway activities (see [ReactomeFIViz wiki page](https://wiki.reactome.org/index.php/ReactomeFIViz#Visualize_Cancer_Drugs_in_Contexts_of_Reactome_Pathways_and_FI_Network)).

To facilitate third-party software tool developers to integrate the powerful network and pathway analysis features provided in ReactomeFIViz, we implemented a new CyREST API. The current version of this API is focused on FI network construction and Reactome pathway enrichment analysis for a set of genes.

Methods
=======

To develop the CyREST API for ReactomeFIViz, we followed the recommended procedures described in [Cytoscape wiki on adding Automation to existing apps](https://github.com/cytoscape/cytoscape-automation/wiki/App-Developers:-Adding-Automation-to-Existing-Apps). To handle the complex data models used in ReactomeFIViz, we chose the Functions over Commands approach by adding JAX-RS resource onto existing ReactomeFIViz code base. In brief, we added two new Java packages, org.reactome.cytoscape.rest and org.reactome.cytoscape.rest.tasks, and refactored original tasks into [ObservableTask](http://code.cytoscape.org/jenkins/job/cytoscape-3-javadoc/javadoc/org/cytoscape/work/ObservableTask.html). All refactored ObservableTasks are grouped into package org.reactome.cytoscape.rest.tasks, and their execution is managed by a SyncrhonousTaskManager object and monitored by their respective [TaskObserver](http://code.cytoscape.org/jenkins/job/cytoscape-3-javadoc/javadoc/org/cytoscape/work/TaskObserver.html) objects.

The ReactomeFIViz CyREST API is specified in a Java interface, ReactomeFIVizResource, and documented using [Swagger UI](https://swagger.io/swagger-ui/) as Java annotations for methods defined in the interface. The implementation of ReactomeFIVizResource is provided in class ReactomeFIVizResourceImp. Both the interface and the implementation are placed in package org.reactome.cytoscape.rest.

The ReactomeFIViz CyREST API is powered up by the CyREST app using its embedded light-weight Grizzly HTTP server. CyREST delegates all RESTful API calls to ReactomeFIViz, which then calls the ReactomeFIViz RESTful server via its RESTful API. The ReactomeFIViz server fetches the Reactome content from databases hosted in a MySQL database engine via a [Hibernate](http://hibernate.org/) API and the in-house built [Reactome Java API](https://github.com/reactome/CuratorTool) ( [Figure 1](#f1){ref-type="fig"}).

![Software architecture for ReactomeFIViz CyREST API.](f1000research-7-16396-g0000){#f1}

Operation
=========

Currently, the ReactomeFIViz CyREST API provides 8 methods ( [Table 1](#T1){ref-type="table"}). These methods allow third-party workflow and pipeline developers to construct a FI sub-network based on a set of genes listed in a variety of file formats, annotate displayed network using collected pathways, GO biological process, molecular function, or cellular component terms, perform network cluster and then annotate network modules. These methods also allow them to perform Reactome pathway enrichment analysis for a set of genes and then export pathway diagrams. The CyREST API document for ReactomeFIViz, which is accessed via menu Help/Automation/CyREST API, provides detailed description about all these resources.

###### List of ReactomeFIViz CyREST API.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  URL                         HTTP\    Function                       Note
                              Method                                  
  --------------------------- -------- ------------------------------ -------------------------------------------------------------------------------------------------------------------
  fiVersions                  GET      List supported versions of\    Usually three versions should be listed
                                       the FI network                 

  buildFISubNetwork           POST     Build a FI subnetwork for a\   Multiple file formats are supported
                                       set of genes                   

  enrichment/{type}           GET      Perform network enrichment\    Four types are supported, which is\
                                       analysis                       specified by type in URL: Pathway, GO\
                                                                      BP ^[1](#fn1){ref-type="table-fn"}^, MF ^[2](#fn1){ref-type="table-fn"}^, and CC ^[3](#fn1){ref-type="table-fn"}^

  cluster                     GET      Perform network clustering\    Clustering is performed for the\
                                       analysis                       displayed network

  moduleEnrichment/{type}     GET      Perform network module\        Four types are supported, which is\
                                       enrichment analysis            specified by type in URL: Pathway, GO\
                                                                      BP, MF, and CC

  pathwayTree                 GET      Show the Reactome\             All pathways are returned from this\
                                       pathway tree                   resource

  ReactomePathwayEnrichment   POST     Perform pathway\               pathwayTree must be called first
                                       enrichment analysis for a\     
                                       set of genes                   

  exportPathwayDiagram        POST     Export a pathway diagram\      Only pathways with hasDiagram\
                                       as a PDF file                  values equal to true can export\
                                                                      diagrams.
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Notes: 1. GO BP: Gene Ontology biological process; 2. MF: Molecular function; 3. CC: Cellular component.

Results
=======

ReactomeFIViz CyREST API provides a set of URL-based language-neutral functions, which accept parameters and return results in the JSON format. As with any other CyREST API, it can be easily integrated into Python, R, or any other programming language as long as it supports HTTP-based function calling. Here we describe a use case based on [The Jupyter Notebook](http://jupyter.org/) to showcase the usage of this API in a workflow development.

Workflow
--------

Previous study ^[@ref-6]^ has shown the genomic similarity between high-grade serous ovarian tumors and basal-like breast tumors based on multiple omics data types, including copy number variants (CNVs), somatic mutations, and mRNA gene expression. To demonstrate use of the ReactomeFIViz CyREST API, we perform a network- and pathway-based comparison analysis between genes having somatic mutations in TCGA ovarian cancer and breast cancer. Our analysis is focused on showing the utility of our API. Therefore, we use all TCGA breast cancer samples without subtyping to simplify our workflow.

[Figure 2](#f2){ref-type="fig"} shows the workflow of this use case, and [Table 2](#T2){ref-type="table"} lists the detailed information for actions performed in the workflow. The TCGA BRCA (breast invasive carcinoma) and OV (ovarian serous cystadenocarcinoma) mutation data was downloaded from the [Broad firehose web site](http://gdac.broadinstitute.org/) in the mutation annotation file (MAF) format using its RESTful API, and stored in two local files, one for each cancer type. The MAF file was then loaded into Cytoscape via the CyREST API, buildFISubNetwork, to construct a FI sub-network after choosing a sample cutoff to select genes forming a network composed of about 500 genes. The FI-network was then subject to network clustering analysis using the cluster call. Two sets of network modules from network clustering were compared to find modules shared and not shared between these two cancers in the Python notebook. Pathway enrichment analysis was performed using ReactomePathwayEnrichment to collect pathways not shared between them. These results suggest common and cancer-specific network and pathway patterns, facilitating researchers to understand shared and specific oncogenesis mechanisms in these two cancers. Finally, pathway diagrams were exported via exportPathwayDiagram.

![The workflow of the comparison analysis use case using TCGA OV and BRCA mutation data.](f1000research-7-16396-g0001){#f2}

###### List of actions performed in the use case workflow.

  ---------------------------------------------------------------------------------------------------------------------------------
  Action          Workspace         URL                                                                  Sample Parameters
  --------------- ----------------- -------------------------------------------------------------------- --------------------------
  Download        Broad firehose\   <http://firebrowse.org/api/v1/Analyses/Mutation/MAF>                 format='tsv'\
                  web site                                                                               cohort='BRCA'

  Build\          Cytoscape         <http://localhost:1234/reactomefiviz/v1/buildFISubNetwork>           file='BRCA.maf'\
  network                                                                                                sampleCutoffValue=4

  Cluster         Cytoscape         <http://localhost:1234/reactomefiviz/v1/cluster>                     none

  Partition by\   Python\           n/a                                                                  cutoff=.05
  overlap         notebook                                                                               

  Annotate        Cytoscape         <http://localhost:1234/reactomefiviz/v1/ReactomePathwayEnrichment>   data=\['ABCA1', 'ACL2',\
                                                                                                         \..., 'ZNF462'\]

  Export\         Cytoscape         <http://localhost:1234/reactomefiviz/v1/exportPathwayDiagram>        dbId=68877\
  diagram                                                                                                \
                                                                                                         pathwayName='Mitotic\
                                                                                                         Prometaphase'\
                                                                                                         \
                                                                                                         fileName='Mitotic\
                                                                                                         Prometaphase.pdf'
  ---------------------------------------------------------------------------------------------------------------------------------

Analysis results
----------------

We performed a network comparison study for the two FI subnetworks constructed separately for TCGA BRCA and OV mutated genes. Network clustering yielded 23 and 38 modules with the TCGA BRCA and OV FI subnetwork, respectively. Overlapping analysis for modules having no less than 3 genes showed 16 out of 18 BRCA modules significantly overlapped with 15 out of 22 OV modules (FDR \< 0.05. Results not shown here. See the output in the notebook for details), implying that almost all of BRCA modules can be found in the OV subnetwork and some of BRCA modules are shared with more than one OV module. For example, BRCA Module 1 is significantly overlapped with OV Modules 2 and 3.

For the pathway comparison study, we focused on pathways enriched for network modules not shared between BRCA and OV, searching for possible different oncogenic mechanisms for these two cancers. The module overlapping analysis showed that BRCA modules 13 and 17, which contains 6 and 4 genes, respectively, are not significantly shared with any OV module using FDR cutoff = 0.05, though detailed analysis showed that Module 13 has one gene, ADCY9, shared with OV Module 1, and Module 17 has another gene, FLG, shared with OV Module 7. Pathway annotation for these two modules revealed that genes in there are significantly enriched for some signaling pathways, including [DAG and IP3 signaling](https://reactome.org/PathwayBrowser/#/R-HSA-1489509), [Signaling by GPCR](https://reactome.org/PathwayBrowser/#/R-HSA-372790), and [Glucagon signaling in metabolic regulation](https://reactome.org/PathwayBrowser/#/R-HSA-163359). There are 7 modules in the OV subnetwork that are not significantly shared with the BRCA subnetwork. Pathway enrichment analysis showed that genes in these modules are significantly involved in [Ion channel transport](https://reactome.org/PathwayBrowser/#/R-HSA-983712), [O-linked glycosylation](https://reactome.org/PathwayBrowser/#/R-HSA-5173105), [C-type lectin receptors](https://reactome.org/PathwayBrowser/#/R-HSA-5621481), and several others. For detailed results, see the output from the notebook.

To visualize mutated genes in the context of Reactome pathways, the notebook also generated two pathway diagrams, one for each cancer, and saved into the working directory as PDF files. Entities in pathway diagrams composed of mutated genes are highlighted in purple.

Discussion
==========

Reactome provides a large set of high-quality manually curated pathways. The Reactome FI network provides a genome-scale highly reliable functional interaction network covering over 60% of total human genes. The ReactomeFIViz CyREST API delivers language neutral REST-based functions for third-party software developers to leverage high-valued resources provided by the Reactome project in their own software tools.

The current set of functions implemented in this version of ReactomeFIViz CyREST API focuses on some major features implemented in ReactomeFIVz, related to FI network construction, clustering, and Reactome pathway enrichment analysis. As shown in the above use case, it is very easy to integrate with other CyREST APIs and integrated into a Python or R programming language environment to perform Reactome-related pathway and network analysis and visualization.

We will expose other ReactomeFIViz features in the CyREST API, including gene expression data analysis, network module-based survival analysis, pathway modeling based on Boolean network and probabilistic graph model, and cancer drug visualization and simulation. We will also develop a Python package for easy third-party tool integration.

Software availability
=====================

Home page for user guide: <https://reactome.org/tools/reactome-fiviz>

Cytoscape app store: <http://apps.cytoscape.org/apps/reactomefiplugin>

Latest source code: <https://github.com/reactome-fi/CytoscapePlugIn/tree/path-x>

Use case Jupyter notebook: <https://github.com/reactome-fi/workflows>

Source code at the time of publication: <https://github.com/reactome-fi/CytoscapePlugIn/releases/tag/f1000_auto_paper> for ReactomeFIViz, <https://github.com/reactome-fi/workflows/releases/tag/f1000_auto_paper> for the Python use case notebook

Archived source code at the time of publication: <http://doi.org/10.5281/zenodo.1226433> ^[@ref-7]^ for ReactomeFIViz, <http://doi.org/10.5281/zenodo.1226430> ^[@ref-8]^ for the Python use case notebook

License: The Creative Commons Attribution 3.0 Unported License ( <http://www.reactome.org/?page_id=362>).

Data availability
=================

The data referenced by this article are under copyright with the following copyright statement: Copyright: © 2018 Loney F and Wu G

Data associated with the article are available under the terms of the Creative Commons Zero \"No rights reserved\" data waiver (CC0 1.0 Public domain dedication). <http://creativecommons.org/publicdomain/zero/1.0/>

Output from the network comparison are available in the Python use case notebook <http://doi.org/10.5281/zenodo.1226430> ^[@ref-8]^

We would like to thank the whole Reactome team for providing the foundation for ReactomeFIViz.
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In this article, the authors have described their extensions to the popular ReactomeFIViz Cytoscape App to support automation via CyREST. They do an excellent job providing the motivation for their extension. The manuscript was clear and well-written, and I believe that the new REST API\'s will be quite useful.

I do have a problem with the manuscript, however, in that in the Workflow section, they state:

\"The MAF was then loaded into Cytoscape via the CyREST API to construct a FI sub-network after choosing a sample cutoff to select genes forming a network composed of about 500 genes. The FI-network was then subject to network clustering analysis. Two sets of network modules from network clustering were compared to find modules shared and not shared between these two cancers. Pathway enrichment analysis was performed to collect pathways not shared between them.\"

My problem with this is that they don\'t provide us with enough detail on the actual CyREST calls and parameters they used to allow us to understand how to reproduce it. Which part of their analysis was done in Python vs. which was done in Cytoscape through the GUI. It is true that all of my answers exist in the Jupyter notebook they provided, but that\'s a lot of work to figure out that they used the \"buildFISubNetwork\" method with the \"MAF\" format the fiVersion \"2016\".  My suggestion is to add at least enough information either in the figure or the text to help others understand the REST flow for their App without referring to the notebook.

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.
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Dear Dr. Morris,

Thanks a lot for reviewing our paper and your comment. In version 2 of our paper, we have added a new table listing detailed information about actions performed in the use case workflow (Table 2), and added new words in the main text (the second paragraph in the Workflow section) to help readers understand how to reproduce the workflow without going to the Jupyter notebook. We hope our revisions have addressed your concern.

Best regards,

Guanming Wu, Ph.D.
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The authors describe the development of CyREST API for ReactomeFIViz, a Cytoscape app, which exposes some Reactome functions as REST APIs for external software components, to process pathway and network data in automatic and reproducible workflows built using almost any programming languages. The source code provided for ReactomeFiViz and for the Python use case notebook, make the use of CyREST API easier and simpler to understand.

The manuscript is well-organized and the described app will be highly valuable for users working with big data related to enrichment analysis and visualization of networks.

I have only some minor comments:  In the Introduction section (pag.2): the sentence "These approaches project significant genes, proteins, metabolites, and other kinds of biological entities collected from pre-analysis onto pathways and networks, knowledge produced by many years' experimental studies.", is not quite understandable, I think it should be rephrased.The Methods section (pag.2) is clearly explained and sufficient details are provided to allow replication of the method development and its use by others.The section Operation (pag.2) I think is unnecessary, the authors can add it as the subsection of Methods because here they are explaining the methods available in the CyREST API developed.In the Analysis results subsection (pag.3): I think it\'s possible to add a figure (such as a Venn Diagram) to better explain the results obtained.In the same subsection (Analysis results: pag.3) more details should be provided about the results. (For example:-       in BRCA modules 13 and 17 are there overlapping genes? If yes, which are their names?-       What is the way, in which the enriched signaling pathways are involved in BRCA and/or OV carcinoma?)More references to supporting literature must be provided in the manuscript in order to further substantiate the claims. 

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Wu
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Dear Dr. Piccirillo,

Thanks a lot for reviewing our paper and your comments. We have made changes to address some of your comments. Please see details below:

1). In the Introduction section (pag.2): the sentence "These approaches project significant genes, proteins, metabolites, and other kinds of biological entities collected from pre-analysis onto pathways and networks, knowledge produced by many years' experimental studies.", is not quite understandable, I think it should be rephrased.

***We have rephrased this sentence and hope the meaning is clear now.***

2). The Methods section (pag.2) is clearly explained and sufficient details are provided to allow replication of the method development and its use by others.

***Thanks! ***

3). The section Operation (pag.2) I think is unnecessary, the authors can add it as the subsection of Methods because here they are explaining the methods available in the CyREST API developed.

***This section is suggested by the article template provided by the journal editor. ***

4). In the Analysis results subsection (pag.3): I think it\'s possible to add a figure (such as a Venn Diagram) to better explain the results obtained.

***Thanks for the suggestion. However, we found that it is difficult to show this type of overlapping result in a Venn diagram. We hope that our text description is clear.***

5). In the same subsection (Analysis results: pag.3) more details should be provided about the results. (For example:

-       in BRCA modules 13 and 17 are there overlapping genes? If yes, which are their names?

***We have added another sentence to address your question in the second paragraph of the Analysis Result section.***

-       What is the way, in which the enriched signaling pathways are involved in BRCA and/or OV carcinoma?)

***This is a great question. However, this short software article is written to showcase how to use the new ReactomeFIViz CyREST API. We have refrained ourselves to discuss the biological implications of our analysis results. However, the exported pathway diagrams may answer questions like this, which will be addressed in our future projects.***

6). More references to supporting literature must be provided in the manuscript in order to further substantiate the claims. 

***Thanks for the comment. Along with listed references, we have also linked to external resources using hyper-links in the main text. We feel that we have cited enough supporting references for this on-line short software article.***

Best regards,

Guanming Wu, Ph.D.

[^1]: No competing interests were disclosed.
